Lenacapavir pacfosacil is an investigational new drug that is being developed by Gilead Sciences for the treatment of HIV-1 infections. It is an orally bioavailable along-acting prodrug of lenacapavir, a HIV capsid inhibitor.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.